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Research Article 
Unusually small sex differentials in mortality of Israeli Jews: 






Since the establishment of Israel sex differentials in life expectancy at birth exhibited 
by Israeli Jews have been very low in comparison to other developed countries as a 
result of relatively high male and relatively low female life expectancy. To advance 
understanding of this phenomenon this paper explores cause-specific contributions to 
the difference in life expectancy between Israeli Jews and Western countries, for each 
sex, and to sex differentials in mortality in both populations. We quantify the major 
types of behaviourally induced mortality to show that it is especially low among Israeli 
Jewish males. We also investigate mortality in certain subgroups of Israeli Jews to gain 
a better understanding of female mortality in this population.  
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1. Introduction  
In the Western world the difference between female and male life expectancies at birth 
grew from an average of 2.4 years in the 1900s to 4.8 years in the 1950s, and 6.2 years 
in the 1990s (United Nations 2004).  The difference peaked approximately in the early 
1980s at 6.6 years and was followed by a decrease (Trovato and Lalu 1996, 1998, 
Pampel 2002, 2005, Trovato and Heyen 2006). Among Israeli Jews the difference 
between female and male life expectancy at birth has been very low in comparison to 
Western countries: it was about 2.9 years in the 1950s, 3.5 years in the 1970s, and 3.8 
years in the 1990s, i.e. it increased slightly and very slowly over time (Central Bureau 
of Statistics, Israel, Statistical Abstract of Israel, 2005). Previous research (see, for 
example, Staetsky and Hinde 2008) has shown that this phenomenon is due to a stable 
pattern of low male and somewhat elevated female mortality at old ages, mainly 60 and 
65 years and over. In the second half of the 1990s life expectancy at birth of Israeli 
Jewish males was 76.3 years, as opposed to an average of 74.3 years among males of 
Western countries. For females the figures were 80.3 years and 80.6 years, respectively 
(Central Bureau of Statistics, Israel, Statistical Abstract of Israel, 2005, United Nations 
2004). Although somewhat different in magnitude, both the survival advantage of 
Israeli Jewish males and the disadvantage of Israeli Jewish females could be traced 
back to the early 1950s.  
The underlying reasons for the widening of sex differentials in mortality in the 
course of the 20
th century have not been completely understood. Most authors in this 
field maintain that there is a possibility that biological/evolutionary factors are in part 
responsible for sex differentials in mortality, but also that both the cross-sectional and 
the temporal variability of the mortality sex differential make biological explanations 
appear insufficient for a full understanding of female survival advantage (Waldron 
1976, 1983, Nathanson 1984, Zhang, Sasaki, and Kesteloot 1995, Luy 2003, Kruger 
and Nesse 2004). While different scholars adopted different positions on the role and 
relevance of changes in women’s status (Nathanson 1995, Pampel 2003), there is 
probably a broad agreement that changes in sex differentials in mortality over the 20
th 
century, at least, result largely from the unequal exposure of females and males to 
health risks associated with modern lifestyles, for example, smoking, alcohol 
consumption, driving of motor vehicles, stress, and an individualistic lifestyle. Initially 
these affected males more than they affected females, causing sex differentials in 
mortality to rise within the categories of cardiovascular diseases, cancer, and external 
causes (Retherford 1975, Preston 1976, Lopez 1983, Waldron 1976, 1986, Valkonen 
and Van Poppel 1997, Nikiforov and Mamaev 1998, Oman and Thorensen 1999, 
Pampel 2003, 2005). A gradual spread of health destructive behaviours, and principally 
smoking, among females of Western countries caused the reversal in sex differentials in 
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mortality (Waldron 1993, Pampel 2001, 2002, 2003, 2005, Waldron, McCloskey, and 
Earle 2005). It is important to remember that in modern times, as in the past, a wide 
range of factors unrelated to sex-specific behavioural patterns operated to reduce or 
enhance sex differentials in mortality. Those factors were labelled by Waldron, 
McCloskey, and Earle (2005) as ‘other societal trends’ and their disproportionate 
impact on one sex is due to their interaction with sex-specific behaviour
3. 
Cause-specific sex differentials in mortality across the developed world have been 
extensively documented in the demographic literature. Of the major groups of causes of 
death, the largest mortality sex differentials were registered in relation to cardiovascular 
diseases (CVD), cancer, and external causes (Lopez 1983, Nathanson 1984, United 
Nations 1988, Waldron 1993, Zhang, Sasaki, and Kesteloot 1995, Nikiforov and 
Mamaev 1998, Waldron, McCloskey, and Earle 2005, Trovato and Heyen 2006). CVD, 
cancer, and external causes are also the main contributors to the change in mortality sex 
differentials, i.e. the increase across many developed countries prior to the 1970s-1980s 
and decrease sometime thereafter (Levi et al. 1992, Waldron 1993, Zhang, Sasaki, and 
Kesteloot 1995, Trovato and Lalu 1998, Pampel 2001, Waldron, McCloskey, and Earle 
2005, Trovato and Heyen 2006). 
During the second half of the 20
th century mortality of developed countries and of 
Israeli Jews was dominated by chronic conditions. Depending on the period, CVD and 
cancer were together responsible for 45%-65% of total mortality. Infectious diseases 
accounted for 7% in the 1950s and for 2% in the 1990s, and the contribution of external 
causes was in a range of 5%-9%. Between the 1950s and the 1990s a massive decline in 
mortality (a gain of 9-10 years in terms of life expectancy at birth) among Israeli Jews, 
as in Western countries, was dominated by chronic diseases, with CVD playing an 
especially prominent role (Thom et al. 1985, Uemura and Pisa 1988, Thom and Epstein 
1994). Cancer, infectious diseases, as well as other medical conditions, and external 
causes all contributed to the decline among females; among males cancer mortality rose 
or remained stable during this period in Israel and elsewhere in the developed world 
(Thom and Epstein 1994).  
To our knowledge, the existing literature does not offer a comprehensive account 
of cause-specific mortality among Israeli Jews, with the focus on mortality sex 
differentials. However, previous research provides important indications in relation to 
the directions to be pursued. At different times research has indicated the presence of 
elevated mortality from cardiovascular diseases among Israeli females (Kark 1976, Ore 
                                                           
3 One example of such a trend is an advancement made by medical science in treatment of accidental falls. 
Females tend to suffer from the kind of falls that are treated especially effectively as a result of this 
development. Therefore, female mortality would be more affected by these developments than male mortality 
(Waldron, McCloskey, and Earle 2005). 
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et al. 1991, Thom et al. 1985, World Health Organization, Highlights on Health in 
Israel 2004 2006a), and in specific sub-groups in this population (Peritz 1986, 
Eisenbach 1994, Friedlander, Schellekens, and Sharashov-Cohen 1995, Kark et al. 
1996, Manor et al. 2000, 2004). Specifically, Kark (1976) observed that Israeli Jews 
born in Africa and Asia (as opposed to European-born and Israeli-born Jews) possess 
especially low sex differentials in mortality and especially high female mortality from 
ischaemic heart disease. He also stated that, in general, in the mid-1960s low ratios of 
male to female death rates among Israeli Jews were due to ‘relatively high female 
mortality rates from ischaemic heart disease’ (Kark 1976: 1198). Manor et al. (2000, 
2004), Eisenbach (1994) and Friedlander, Schellekens, and Sharashov-Cohen (1995) 
demonstrated the lasting nature of elevated mortality in the African-born females. 
Breast cancer among Israeli females was shown to be relatively high at many (but not 
all) points in time (Althuis et al. 2005, World Health Organization, Highlights on 
Health in Israel 2004 2006a). In relation to total cancer, however, the picture was less 
consistent (World Health Organization, Highlights on Health in Israel 1996, World 
Health Organization, Highlights on Health in Israel 2004 2006a), with periods of both 
high (1970s and 1990s) and low (1980s) cancer rates. Recent advances in genetic 
research have revealed that there is an increased presence of the so-called breast cancer 
genes in Jewish populations (Feldman 2001, Lynch, Rubinstein, and Locker 2004, 
Rubinstein 2004). These genes may cause elevated risks of breast and ovarian cancer in 
females and prostate cancer in males. They may also contribute to other types of cancer. 
It is important to note, however, that breast cancer mortality among Israeli Jewish 
females was not the highest in the developed world; in fact, breast cancer mortality in 
some Anglophone countries and Denmark was higher than in Israel both in the 1970s 
and 1990s (Althuis et al. 2005). High lung cancer mortality among Israeli Jewish 
females born in Europe was noted in the 1950s (Rakower 1957) but not subsequently 
(Lopez 1995, World Health Organization, Highlights on Health in Israel 1996). On the 
other hand, relatively low mortality from total cancer, lung cancer, certain types of 
external causes, and, at times, also from cardiovascular diseases among Israeli males 
was also noticed (Rakower 1957, Thom et al. 1985, Rennert et al. 1988, 1990, Lopez 
1995, World Health Organization, Highlights on Health in Israel 1996). Relatively low 
levels of cirrhosis of the liver (World Health Organization, Highlights on Health in 
Israel 2004 2006a), and a relatively high level of colorectal cancer (Feldman 2001) 
were reported to be present in both sexes in the Israeli population. Shkolnikov et al. 
(2004) provided an informative insight into the causes of small sex differentials in 
mortality among Israeli Jews, showing similar structures of the life expectancy 
difference between the two sexes for both Russian and Israeli Jews in the 1990s. The 
contribution of every cause examined to the overall differential between the sexes 
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among Israeli Jews and among Russian Jews was much smaller than in both the 
Russian population and the populations of selected Western countries. 
Relatively small sex differentials are a recurrent finding in the literature on Jewish 
Diaspora mortality within the context of the developed world, specifically in the United 
States of America, Canada, England and Wales, and Russia (Needleman 1988, 
Rosenwaike 1990, 1994, Shatenstein and Kark 1995, Goldstein 1996, Shkolnikov et al. 
2004, Haberman and Schmool 2005). It is important to note, however, that in contrast 
to Israel where the phenomenon of elevated old-age female mortality relative to the 
average of Western countries persisted into the 1990s, since approximately the 1970s 
both male and female old-age mortality among Jewish populations outside Israel was 
lower than in their host populations. Therefore, while small sex differentials remained 
the core characteristic of the Jewish mortality in Israel and in other Jewish communities 
for the large part of the 20
th century, it was maintained by variable combinations of sex-
specific mortality schedules. Importantly, elevated female mortality proved to be a 
transient feature (Staetsky and Hinde 2008). 
This paper addresses the following questions:  
 
1.  For each sex, is the difference between the mortality of Israeli Jews and 
Western countries attributable to specific causes or groups of causes? 
2.  For sex differentials in mortality, is the difference between Israeli Jews and 
Western countries attributable to specific causes? 
 
Staetsky and Hinde (2008) put forth two hypotheses to explain the observed sex 
differentials in mortality among Israeli Jews. The first hypothesis made the connection 
between the low level of behaviourally induced mortality (and especially lung cancer 
mortality) among Israeli Jewish males and their low overall mortality. The second 
hypothesis explained the elevated mortality of Israeli Jewish females as a function of 
their migrant origin, i.e. their origin in societies characterised by relatively high 
mortality. In this account of causes of death an attempt is made to seek further evidence 
supporting or contradicting both hypotheses. We will explore the first hypothesis by 
implementing a quantification of the behaviourally induced mortality. The second 
hypothesis will be put to the test through an examination of the mortality of Israeli-born 
(i.e. non-migrant) Jews.  
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2. Data and method  
2.1 Data  
The mortality and population data for all comparator countries at all points in time 
come from the World Health Organization Statistical Information System (World 
Health Organization 2006b) which provides information on cause-specific deaths by 
sex and age, as well as population estimates in a corresponding format. Mortality data 
for Israeli Jews in the 1950s and 1970s come from the same source while for the 1990s 
they come from special data files prepared by the Central Bureau of Statistics, Israel. 
Population estimates of Israeli Jews in the 1950s and 1970s are taken from the annual 
publications of the Central Bureau of Statistics (Central Bureau of Statistics, Israel, 
Statistical Abstract of Israel, various years) and, in the 1990s, from a special data file 
prepared by the Central Bureau of Statistics, Israel. 
 
 
2.2 Method  
The principal technique used to address the research questions posed in this paper is the 
decomposition of the difference between two groups in life expectancy at birth into age- 
and cause-contributions. A number of approaches can be used for the cause 
decomposition of a mortality differential between groups, as expressed by the 
differential between life expectancy figures (Retherford 1975, Pollard 1982, 1988, 
Arriaga 1984, Pressat 1985, United Nations 1988, Das Gupta 1993, Trovato and Lalu 
1998, Andreev, Shkolnikov, and Begun 2002, Vaupel and Canudas-Romo 2002, 
Trovato 2005, Trovato and Heyen 2006, Beltran-Sanchez and Preston 2007, Horiuchi, 
Wilmoth, and Pletcher 2008). Recent research into the properties of selected approaches 
has not revealed great differences between the results of their application (Andreev, 
Shkolnikov, and Begun 2002, Vaupel and Canudas-Romo 2002, Ponnapalli 2005, 
Beltran-Sanchez and Preston 2007). To our knowledge, a study of Jewish mortality in 
Moscow conducted by Shkolinikov et al. (2004) was the first to implement the 
decomposition of the difference in life expectancy into age- and cause-contributions 
within the context of Jewish mortality research. In this analysis we employ the United 
Nations method of decomposition (United Nations 1988, p. 105). The approach is 
chosen due to its precision, conceptual clarity and computational simplicity.  
Since sex differentials are essentially a result of the interaction of sex-specific 
mortality schedules (Trovato and Lalu 1998), comparisons of sex-specific trends and 
levels are employed extensively throughout this study. Additionally, mortality sex 
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differentials are calculated and presented. Using the United Nations’ method of 
decomposition we calculate age- and cause-contributions to the difference between life 
expectancy at birth of (1) Israeli Jewish males and males of comparator countries; (2) 
Israeli Jewish females and females of comparator countries, and (3) females and males 
among Israeli Jews and in comparator countries. 
The processes of widening and narrowing of sex differentials during the 20
th 
century varied from place to place. However, since the focus of this paper is on 
mortality sex differentials in the Jewish population of Israel, this population will be 
compared to average measures of the populations of developed countries. This would 
also help to avoid a potentially overwhelming number of country-specific comparisons.  
Effectively, we create a single comparator for Israeli Jews using age, sex and cause-
specific death rates of 18 Western countries for three points in time (1951-53, 1973-75, 
and 1995-97). The comparator population is therefore an unweighted average of the 
death rates of these countries. The 18 comparator countries are Australia, Austria, 
Belgium, Canada, England and Wales, Finland, France, Italy, Greece, Denmark, the 
Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, and the 
United States of America
4. As sex differentials in mortality of developed countries have 
been dynamic over the second half of the 20
th century, we choose to focus on the early 
1950s, mid-1970s, and mid-1990s. The distinctiveness of the 1950s, 1970s, and 1990s 
in relation to sex differentials in mortality has been suggested by the previous research 
(United Nations 1988, Waldron 1993, Zhang, Sasaki, and Kesteloot 1995, Trovato and 
Lalu 1996, 1998, Waldron, McCloskey, and Earle 2005, Trovato and Heyen 2006). As 
a result, it is possible to compare Israeli Jews to developed countries at the time of 
increase of sex differentials in mortality (1950s), their peak (1970s), and at the time of 
decrease in many Western countries (1990s).  
With a few exceptions, we resort to broad groupings of the causes of death in order 
to minimise complications arising from the application of different practices of causes- 
of-death classification in different countries and periods of time (Janssen and Kunst 
2004). Also, averaging across countries is a technique that may overcome cross national 
differences in coding of causes and diagnostic practices. Any temporal and cross 
country comparisons of detailed codes of causes of death should be exercised with 
caution, though, in general, male-female comparisons within one country are safer than 
                                                           
4 For most countries average death rates over three-year periods were calculated to enhance the stability of the 
rates, except for a few countries where information in this format was unavailable. Consequently, in the 
1990s, for Finland, the Netherlands, and Norway only death rates for 1995 were used; for Sweden an average 
of years 1995-1996; for Denmark an average of 1992-1993, and for Switzerland an average of 1993-1994. In 
the 1950s, for Finland and France an average of 1952-1953 was created, for Austria and Portugal an average 
of 1955-1956; for Belgium an average of 1954-1956, and for Greece an average of 1961-1962. 
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inter country comparisons within the same sex. Construction of the groupings of causes 
of death was performed as specified in Table 1:  
 
 
Table 1:  International classification of diseases (ICD) codes of causes of death  
  taking part in the decomposition exercise 
 
Conditions Version  of  ICD 
     7th revision  8th revision  9th revision 
    
(A-list, condensed) (A-list, condensed) (Basic Tabulation 
List, condensed) 
Major groups          
 Infectious  diseases  A001-A043 A001-A044  B01-B07   
  Malignancies (cancer)  A044-A060  A045-A061  B08-B14  
  Cardiovascular diseases (CVD)  A070, A079-A086  A080-A088  B25-B30  
 External  causes  A138-A150  or CH17  A138-A150   B47-B56  
  all remaining codes  all remaining codes  all remaining codes 
 
Other, including ill-defined 
causes      
Selected detailed codes          
  Breast cancer  A051   A054   B113  
  Lung cancer  A050  A051  B101  
  Aerodigestive cancer  A044, A045, A049  A045, A046, A050  B08, B090, B100 
  Heart disease  A080, A081, A082  A081, A083, A084  B251, B27, B28 (1) 
 Cerebrovascular  disease  A70  A080  B29 
  Transport accidents  A138, A139  A138, A139  B47 
  Cirrhosis of the liver  A105  A102  B347 (2) 
 
Note: (1) For Israeli Jews in the 1990s causes of death under the code B025 were incorporated in the category of heart disease, due 
to the nature of groupings supplied by the Central Bureau of Statistics, Israel. This category included only a small number of 
cases (10 cases across all age groups for Israeli Jewish males in 1995, for example). 
(2) For Israeli Jews in the 1990s all chronic liver diseases under the detailed ICD-9 codes 570-573 are used, due to the nature 
of the groupings supplied by the Central Bureau of Statistics, Israel. 
 
 
In Israel the 7
th revision of the ICD was implemented during 1951-1968; the 
subsequent transitions to the 8
th and 9
th revisions of ICD took place in 1969 and 1979, 
respectively. Similar timing of the transitions was observed in other countries.  
Concordance tables developed by Janssen and Kunst (2004), Uemura and Pisa 
(1988) and Levi et al. (1992) were consulted for the creation of comparable categories 
of causes of death over time and across countries. 
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3. Causes of death of Israeli Jews (total population) in comparative 
perspective  
3.1 Israeli Jewish males versus males in Western countries  
Cause-specific contributions to the difference in life expectancy at birth between Israeli 
Jewish males and males of Western countries (hereafter described as ‘other males’) are 
shown in Figure 1 and Table 2.  Probably the most important observation here is that 
the relative survival advantage of Israeli Jewish males is formed by many causes of 
death at all points in time, and that it grows stronger over time due to the influence of 
both natural and external causes. In addition, one can see that all ages 25 years and over 
contribute significantly to the Israeli Jewish male survival advantage. 
 
 
Figure 1:  Cause-specific contributions to the difference in life expectancy  
  at birth between Israeli Jewish males and males of Western countries,  



















Note: CVD-cardiovascular diseases. 
Source: Central Bureau of Statistics, Israel (Statistical Abstract of Israel, various years); special datafiles 
prepared by the Central Bureau of Statistics, Israel; World Health Organization (2006b). 
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Table 2:  Cause- and age-specific contributions to the difference in life  
  expectancy at birth between Israeli Jewish males and males  
  of Western countries, 1950s-1990s 
 


















































































































































                
      1950s          
               
0-24    -0.03   0.00    -0.31    -0.28   0.23     0.01   -0.05  0.00  0.00  -    -0.02   -0.40 
25-44   0.04   0.03    0.04   0.14   0.11     0.02  0.01  0.01  0.00  -   0.01  0.36 
45-64    -0.14   0.23    0.14   0.12   0.25      -0.04   -0.17  0.12  0.03  -   0.06  0.60 
65+   0.37   0.13    0.02    -0.05   0.06      -0.03  0.22  0.02  0.00  -   0.02  0.54 
                          
total   0.24   0.39    -0.10    -0.07   0.65      -0.04  0.01  0.14  0.04  -   0.07  1.11 
                    
      1970s                
               
0-24   0.03    -0.01    0.14    -0.02    -0.20     0.01  0.01  0.00  0.00  0.18  0.00   -0.06 
25-44   0.03   0.00    0.21   0.01   0.05     0.02  0.00  0.00  0.01  0.08  0.04  0.30 
45-64    -0.01   0.30    0.14   0.03   0.14      -0.02   -0.04  0.17  0.06  0.02  0.10  0.60 
65+    -0.15   0.29   0.04    -0.02    0.33     -0.01   -0.27  0.14  0.04   -0.01  0.04  0.48 
                        
total    -0.10   0.58    0.53    -0.01   0.33     0.01   -0.29  0.31  0.11  0.27  0.18  1.33 
                    
      1990s                
               
0-24   0.03   0.01    0.21   0.01    -0.09     0.01  0.02  0.00  0.00  0.09  0.00  0.18 
25-44   0.07   0.03    0.29   0.00   0.09     0.02  0.04  0.01  0.01  0.07  0.03  0.48 
45-64   0.24   0.32    0.10    -0.01    -0.07     0.01  0.19  0.15  0.09  0.02  0.08  0.58 
65+   0.46   0.37    0.00    -0.06    -0.07     0.10  0.20  0.23  0.04  0.00  0.01  0.70 
                        
total   0.79   0.73    0.60    -0.06    -0.13     0.13  0.45  0.39  0.14  0.19  0.11  1.93 
 
Note: CVD-cardiovascular diseases. 
Source: Central Bureau of Statistics, Israel (Statistical Abstract of Israel, various years); special data files prepared by the Central 
Bureau of Statistics, Israel; World Health Organization (2006b). 
 
 
The survival advantage of Israeli Jewish males is especially prominent and strong 
in relation to cancer. Cancer alone is responsible for around 0.4-0.7 years of the total 
survival advantage (a range of 1.1-1.9 years). A large part of this advantage (0.2-0.5 
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years) is due to survival advantage from smoking-related types of cancer, i.e. cancer of 
lung and aerodigestive cancer. Survival advantage from all cancers and smoking-related 
cancers is present both at typical ages of premature mortality (45-64 years) and older 
ages (Table 2).  
The situation in relation to CVD and ‘other’ natural causes (diseases other than 
cancer, CVD and infectious diseases) is less clear cut. In the 1990s and the 1950s CVD 
appears as one of the strong forces shaping survival advantage of Israeli Jewish males: 
its contribution is around 0.8 years and 0.24 years, respectively. That is, however, not 
the case in the 1970s when Israeli Jewish males are at some survival disadvantage 
relative to their counterparts in developed countries. The difference between Israeli 
Jewish males and other males in relation to CVD is mainly due to heart disease. The 
mortality of Israeli Jewish males from cerebrovascular diseases does not appear to be 
very different from what is observed elsewhere among males.  Natural causes other than 
cancer, CVD, and infectious diseases represented a strong factor in the survival 
advantage of Israeli Jewish males in the 1950s (about 0.7 years) and 1970s (about 0.3 
years) but not in the 1990s.  
Apart from smoking-related cancers Israeli Jewish males also demonstrate survival 
advantage relative to other males for other major behaviourally induced types of 
mortality: external causes (broadly related to risk taking behaviour) and cirrhosis of the 
liver (an indication of the scope of alcohol misuse). In absolute terms, external causes 
are third in significance after CVD and cancer. In the 1970s and 1990s they are 
responsible for 0.5-0.6 years of survival advantage of Israeli Jewish males relative to 
other males. The pattern is especially strong for ages 25-44 years and 45-64 years, i.e. 
again, ages of premature mortality. In the 1950s the survival advantage of Israeli Jewish 
males from external causes was observed for all ages but 0-24 years. Survival 
disadvantage from external causes at these ages could be partly related to the existence 
of combat mortality among Israeli Jews. However, this is only an informed guess. Due 
to the nature of the coding of causes of deaths for these years (all external causes are 
brought together under a single code), this is not something that can be further explored. 
Detailed examination of age- and cause-contributions (not shown here) reveals that a 
large part of the survival disadvantage of Israeli Jewish males at ages 0-24 years comes 
from ages 15-19 and 20-24 years, i.e. ages where the toll of combat mortality is the 
highest
5. Israeli Jewish males show an invariable advantage in mortality from cirrhosis 
of the liver (approximately 0.1-0.2 years of the total difference in life expectancy). 
                                                           
5 Combat mortality is excluded from the official statistics for major events of military hostilities between 
Israel and neighboring countries (1956, 1967 and 1973), but not for other events and points in time (Central 
Bureau of Statistics, Israel, Statistical Abstract of Israel, 2007). 
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The only cause of death where Israeli Jewish males are at a constant disadvantage 
is infectious diseases, but the contribution of this cause to the total mortality is low, 
especially during the 1970s and 1990s. 
To further illustrate the role of the avoidable causes of death in the survival 
advantage displayed by Israeli Jewish males we obtain the joint contribution of lung 
cancer, aerodigestive cancer, cirrhosis of the liver, and external causes of death to the 
differential by summation. It is well known that nearly all of lung cancer deaths and a 
very large proportion of deaths from aerodigestive cancer are smoking-related and 
therefore could be prevented (Ravenholt 1990, Peto et al. 1992, 1994, Lopez, 
Collishaw, and Piha 1994). In a similar way, a very large proportion of deaths from 
cirrhosis of the liver and deaths from external causes could be averted in the absence of 
alcohol misuse and risk taking behaviour. A number of recent studies tried to quantify 
avoidable mortality based on the identification of avoidable (preventable and/or 
treatable) causes of death (Nolte and McKee 2003, Andreev et al. 2003, Nolte, Scholz, 
and McKee 2004, Nolte and McKee 2004). The methods used to achieve this are not 
completely uncontroversial (Nolte and McKee 2003, 2004), and we do not attempt to 
implement them because the nature of the groupings of causes of death available for 
Israeli Jews is not suitable for this purpose. Instead, we resort to the causes of death that 
are related to health damaging behaviour in the most unambiguous manner. Nearly all 
deaths from these causes can be averted through prevention.  
Table 3 presents the joint contribution of lung cancer, aerodigestive cancer, 
cirrhosis of the liver, and external causes (defined here as avoidable mortality) to the 
difference in life expectancy between Israeli Jewish males and males of Western 
countries.  
 
Table 3:  Contributions of causes of death representing major types of  
  avoidable mortality to the difference in life expectancy at birth  









     years   
1950s 1.11  0.16  0.95 
1970s 1.33  1.14  0.19 
1990s 1.93  1.25  0.69 
 
Note: (1) Figures may not sum exactly due to rounding. (2) Avoidable mortality is defined here as mortality 
from lung cancer, aerodigestive cancer, cirrhosis of the liver, and external causes. 
Source: Central Bureau of Statistics, Israel (Statistical Abstract of Israel, various years); special datafiles 
prepared by the Central Bureau of Statistics, Israel; World Health Organization (2006b). 
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Even this imperfect quantification of avoidable mortality indicates quite clearly 
that a significant part of the survival advantage of Israeli Jewish males over males in 
other Western countries is due to the lower avoidable mortality of the former: 1.25 
years out of 1.93 years (65%) of survival advantage shown by Israeli Jews in relation to 
their Western counterparts in the 1990s is due to the difference in mortality from 
smoking- related cancers, cirrhosis of the liver, and external causes. The contribution of 
these causes of death to the difference between the two groups is also large in the 
1970s. It is smaller, both in an absolute and in a proportionate sense, in the 1950s, 
indicating that the gap between Israeli males and males in other Western countries in 
relation to major causes of avoidable mortality has widened over time. 
Quantification of avoidable mortality by simple summation of its most typical 
causes is an imperfect tool. In reality, the impact of various health destructive 
behaviours on total mortality is larger since it also affects causes such as cardiovascular 
diseases and other types of cancer, for example. These effects are difficult to isolate. 
Consequently, what Table 3 shows is perhaps only the minimum possible contribution 
of avoidable mortality.  
 
 
3.2 Israeli Jewish females versus females in Western countries  
Figure 2 and Table 4 show the cause-specific contributions to the difference in life 
expectancy at birth between Israeli Jewish females and their counterparts in Western 
countries. It is quite clear that the relative survival disadvantage of Israeli Jewish 
females is also multicausal. It is also clear that, as opposed to male survival advantage, 
female disadvantage diminishes towards the 1990s, and it is most ‘stubborn’ for ages 65 
years and over. In absolute terms, overall, it is also less strong than the male survival 
advantage, with the exception of the 1970s.  
Disadvantage in relation to cancer mortality is one persistent feature of the survival 
disadvantage of Israeli Jewish females: cancer contributed, depending on period, 0.2-
0.3 years to the total differential between life expectancy at birth of Israeli Jewish 
females and females in comparator countries (a range of 0.3-2.2 years). About one-third 
of it in the 1950s and 1970s and nearly all of it in the 1990s was due to breast cancer. 
The survival disadvantage of Israeli females from all cancers was especially persistent 
at ages 65 years and over. Interestingly, Israeli Jewish females displayed survival 
advantage over females in comparator countries in relation to smoking-related cancers 
in the 1990s, but not at earlier times (however, their survival disadvantage in relation to 
lung cancer in the 1950s and 1970s was relatively small).  
Natural causes other than CVD, cancer, and infectious diseases are another 
consistent and at times large contributor to the relative survival disadvantage of Israeli 
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Jewish females, responsible at different times for the range of 0.1-0.5 years in terms of 
life expectancy at birth. On the other hand, CVD did not display any clear pattern. 
Israeli Jewish females were at some disadvantage in the 1950s, and at a very strong 
disadvantage in the 1970s. Both cerebrovascular diseases and heart disease contributed 
to this pattern. In contrast, during the 1990s Israeli Jewish females displayed a clear 
survival advantage from CVD. This was largely due to their survival advantage from 
cerebrovascular diseases, as survival disadvantage from heart disease (sustained by ages 
65 years and over) continued into the 1990s.  
 
 
Figure 2:  Cause-specific contributions to the difference in life expectancy  
  at birth between Israeli Jewish females and females of Western  























Note: CVD-cardiovascular diseases. 
Source: Central Bureau of Statistics, Israel (Statistical Abstract of Israel, various years); special data files 
prepared by the Central Bureau of Statistics, Israel; World Health Organization (2006b). 
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Table 4:  Cause- and age-specific contributions to the difference in life  
  expectancy at birth between Israeli Jewish females and females  
  of Western countries, 1950s-1990s  
 
































































































































































                  
      1950s         
                    
0-24    -0.05  0.00   -0.10   -0.23 -0.09    0.01   -0.06  0.00  0.00  0.00 -    -0.01   -0.47 
25-44   -0.03   -0.05 -  0.05  0.09 0.01     0.01  -0.06  -0.01  -0.04   0.00 -    0.00   -0.04 
45-64   -0.12   0.00   -0.08  0.01 0.04    -0.08  -0.12  -0.01  -0.02   0.00 -    0.02   -0.16 
65+   0.11   -0.11 -  0.08  -0.05 -0.03    -0.25   0.11  -0.02   0.01  -0.01 -    0.01   -0.17 
 
                          
total   -0.09   -0.17   -0.32  -0.19 -0.08  -0.31  -0.13  -0.04  -0.05  -0.01 -   0.03   -0.84 
                     
      1970s            
                    
0-24   0.02  0.00   0.07   -0.01 -0.18  0.01  0.01  0.00  0.00  0.00  0.05  0.00   -0.10 
25-44   0.02   -0.05   0.05  0.00 0.03  0.02   -0.01  0.00   -0.03  0.00  0.01  0.02  0.05 
45-64   -0.39   -0.14   -0.01  0.00 -0.05  -0.11  -0.29   0.00  -0.06   0.00  -0.02   0.03   -0.59 
65+   -1.39   -0.13 -  0.09  -0.04 0.10  -0.39  -1.04  -0.02  -0.02  -0.01  -0.02   0.01   -1.54 
          
total   -1.74   -0.32  0.02  -0.04 -0.11  -0.47  -1.33  -0.01  -0.11  -0.01   0.01   0.05   -2.18 
                     
      1990s            
                    
0-24   0.02  0.01   0.08  0.01  0.03  0.00  0.01  0.00  0.00  0.00  0.04  0.00  0.14 
25-44   0.04   -0.02   0.09  0.00  0.04  0.02  0.01  0.01   -0.01  0.00  0.02  0.02  0.15 
45-64   0.07  0.02   0.05   -0.01   -0.04  0.03  0.02  0.06   -0.04  0.01  0.00  0.05  0.10 
65+   0.11   -0.17   -0.03  -0.09  -0.48   0.18  -0.16   0.04  -0.09   0.01  -0.01  -0.01   -0.65 
          
total   0.24   -0.15   0.19   -0.09   -0.45  0.23   -0.11  0.11   -0.14  0.02  0.06  0.05   -0.26 
 
Note: CVD-cardiovascular diseases. 
Source: Central Bureau of Statistics, Israel (Statistical Abstract of Israel, various years); special datafiles prepared by the Central 
Bureau of Statistics, Israel; World Health Organization (2006b). 
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In a way similar to males, Israeli Jewish females displayed a consistent survival 
advantage in relation to cirrhosis of the liver and a disadvantage in relation to infectious 
diseases. The situation in relation to external causes of death is somewhat puzzling. 
Israeli Jewish females exhibit survival advantage from these causes relative to their 
counterparts in the 1990s (0.2 years) and 1970s (0.02 years) but not in the 1950s, when 
a clear survival disadvantage (0.3 years) is observed. Moreover, even in the 1970s and 
1990s older age groups among Israeli Jewish females retain a certain amount of 
survival disadvantage. Does this actually mean that elderly Israeli Jewish females tend 
to more risky behaviour than similarly aged females in other countries? This is not 
necessarily true as mortality from external causes at ages 45 years and over will also be 
influenced by the state of general health.  Mortality from accidental falls in old age is 
related to increased frailty, which stems from various chronic conditions associated 
with old age (Waldron, McCloskey, and Earle 2005). Given that Israeli Jewish females 
demonstrate higher mortality from chronic conditions as well, higher mortality from 
accidental deaths might not appear as a surprise. It is impossible, with the available 
data, to offer any interpretation of the survival disadvantage of Israeli Jewish females 
from external causes at ages younger than 45 years and especially at ages 0-24 years in 
the 1950s. It is worth remembering that females are almost unaffected by combat 
mortality but are affected by the acts of political violence targeting the civilian 
population of Israel. Also, survival as a result of accidents is affected by the level of 
medical care and general socioeconomic situation. One must remember that the early 
1950s were a period of significant strain on the Israeli medical system, and other 
aspects of the state material infrastructure due to mass migration (Hacohen 2003). More 
work is needed to disentangle this particular issue taking into consideration all possible 
aspects of socioeconomic conditions, the political situation, and the level of medical 
care. 
Examination of the contribution of avoidable mortality (Table 5) to the difference 
between Israeli Jewish females and other Western females demonstrates that in the 
1990s Israeli Jewish females showed lower mortality from typical avoidable causes, and 
in the 1970s the difference between Israeli Jewish females and Western females in 
mortality from avoidable causes was negligible. During the 1970s and 1990s the 
survival disadvantage of Israeli Jewish females seems to be exclusively due to 
nonavoidable mortality. 
In the 1950s, in contrast, avoidable mortality constitutes about 42% of the total 
survival disadvantage of Israeli females; a significant part. However, it does not 
dominate the total survival disadvantage of Israeli Jewish females. 
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Table 5:  Contributions of causes of death representing major types of  
  avoidable mortality to the difference in life expectancy at birth  









     years   
1950s   -0.84   -0.35   -0.50 
1970s    -2.18  0.06   -2.24 
1990s    -0.26  0.38   -0.64 
 
Note: (1) Figures may not sum exactly due to rounding. (2) Avoidable mortality is defined here as mortality 
from lung cancer, aerodigestive cancer, cirrhosis of the liver, and external causes. 
Source: Central Bureau of Statistics, Israel (Statistical Abstract of Israel, various years); special data files 
prepared by the Central Bureau of Statistics, Israel; World Health Organization (2006b). 
 
 
3.3 Sex differentials in mortality: Israeli Jews versus Western countries  
Figure 3 and Tables 6-7 compare cause-specific contributions to sex differentials in 
mortality among Israeli Jews with those in comparator countries. For all major 
groupings of causes of death apart from infectious diseases the contributions to sex 
differentials in mortality of Israeli Jews are significantly smaller than in comparator 
countries. This is especially prominent in relation to cancer and CVD. In the 1990s 
cancer contributes approximately 1.5 years to the sex differential in mortality in 
Western countries, and only about 0.5 years among Israeli Jews. For CVD the figures 
are about 2.0 years and 1.4 years, respectively. Interestingly, in Israel, as in Western 
countries, the sex differential in mortality from CVD is largely shaped by the 
differentials in mortality from heart disease. However, while in Western countries 
cerebrovascular diseases contribute minimally to female survival advantage, among 
Israeli Jews during the 1950s and 1970s cerebrovascular mortality seems to have 
negative contributions. In relation to both cancer and CVD the gap between Israeli Jews 
and the comparator countries is even larger in the 1970s than it is in the 1990s (Table 
6). In the 1950s cancer contributes negatively to the difference between female and 
male life expectancy at birth among Israeli Jews, while its contribution is strongly 
positive in comparator countries (Table 7). 
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Figure 3:  Cause-specific contributions to the difference between female  


















Note: CVD-cardiovascular diseases. 




For CVD, age groups 65 years and over among Israeli Jews are particularly 
different from the comparator countries in terms of the size of their contributions to sex 
differentials in mortality. For external causes this applies also to younger adult ages 
(25-44 years). A truly striking feature of cancer mortality among Israeli Jews is that at 
ages 45-64 years cancer contributes negatively to the difference between life 
expectancy of the two sexes among Israeli Jews. Contribution of cancer mortality to sex 
differentials is also much lower among Israeli Jews at ages 65 years and over. Breast 
cancer consistently reduces the sex differential in mortality among Israeli Jews more 
than it does in Western populations, while smoking-related cancers inflate the sex 
differentials less among Israeli Jews relative to Western countries. 
 
226   http://www.demographic-research.org Demographic Research: Volume 20, Article 11 
Table 6:  Cause- and age-specific contributions to the difference in life  
  expectancy at birth between females and males among Israeli Jews,  
 1950s-1990s 
 
































































































































































                  
      1950s         
                    
0-24   0.00   0.03  0.69  0.08  0.28    0.00  0.00  0.00  0.00  0.00 -   0.01  1.07 
25-44  0.02    -0.16  0.36  0.03   -0.09     -0.01  0.03  0.00   -0.09  0.00 -   0.00  0.15 
45-64  0.75    -0.14  0.05  0.08  0.19     -0.03  0.74  0.05   -0.19  0.03 -   0.01  0.94 
65+   0.14   0.07   -0.03  0.08  0.43     -0.18  0.29  0.06   -0.09  0.06 -   0.01  0.70 
                            
total   0.90    -0.19  1.07  0.28  0.81     -0.22  1.06  0.12   -0.37  0.09 -   0.04  2.86 
                     
      1970s            
                    
0-24   0.00   0.04  0.44  0.03  0.38    0.00  0.00  0.00  0.00  0.00  0.14  0.00  0.89 
25-44  0.14    -0.08  0.30  0.01  0.09    0.00  0.14  0.02   -0.10  0.00  0.14  0.01  0.46 
45-64  0.85    -0.16  0.13  0.01  0.23    0.01  0.81  0.13   -0.27  0.02  0.06  0.03  1.05 
65+   0.26   0.26   -0.04  0.03  0.30     -0.15  0.45  0.16   -0.13  0.02  0.03  0.02  0.82 
                          
total   1.25   0.06  0.83  0.08  0.99     -0.14  1.41  0.30   -0.49  0.04  0.37  0.07  3.22 
                     
      1990s            
                    
0-24   0.00   0.02  0.19  0.00  0.25    0.00  0.00  0.00  0.00  0.00  0.09  0.00  0.46 
25-44  0.07    -0.08  0.23  0.03  0.19    0.00  0.07  0.01   -0.09  0.00  0.08  0.02  0.44 
45-64  0.58    -0.01  0.17  0.03  0.41    0.08  0.46  0.15   -0.30  0.03  0.04  0.06  1.18 
65+   0.78   0.55  0.09  0.03  0.51    0.13  0.64  0.24   -0.26  0.05  0.02  0.04  1.95 
                          
total   1.43   0.47  0.69  0.08  1.36    0.21  1.16  0.40   -0.65  0.09  0.24  0.11  4.03 
 
Note: CVD-cardiovascular diseases. 
Source: Central Bureau of Statistics, Israel (Statistical Abstract of Israel, various years); special data files prepared by the Central 
Bureau of Statistics, Israel; World Health Organization (2006b). 
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Table 7:  Cause- and age-specific contributions to the difference in life  
  expectancy at birth between females and males in Western countries,  
 1950s-1990s 
 
































































































































































                  
      1950s         
                    
0-24   0.01   0.03  0.46  0.01  0.60    0.00  0.01  0.00  0.00  0.00  0.20  0.00  1.11 
25-44  0.09    -0.07  0.45  0.09  0.01    0.00  0.09  0.02   -0.06  0.00  0.18  0.01  0.57 
45-64  0.68   0.12  0.28  0.20  0.42    0.00  0.65  0.19   -0.16  0.07  0.08  0.06  1.70 
65+   0.50   0.31  0.07  0.07  0.49    0.01  0.45  0.10   -0.09  0.07  0.03  0.03  1.43 
                          
total   1.29   0.38  1.26  0.38  1.52    0.02  1.19  0.30   -0.31  0.14  0.50  0.10  4.81 
                     
      1970s            
                    
0-24   0.01   0.03  0.52  0.02  0.35    0.00  0.01  0.00  0.00  0.00  0.29  0.00  0.93 
25-44  0.16    -0.03  0.49  0.01  0.12    0.01  0.15  0.02   -0.07  0.01  0.21  0.03  0.74 
45-64  1.20   0.30  0.29  0.04  0.45    0.09  1.05  0.32   -0.22  0.09  0.11  0.13  2.27 
65+   1.23   0.75  0.08  0.03  0.69    0.16  0.98  0.36   -0.12  0.08  0.04  0.06  2.77 
                          
total   2.60   1.05  1.38  0.10  1.60    0.25  2.18  0.70   -0.41  0.18  0.65  0.22  6.72 
                     
      1990s            
                    
0-24   0.01   0.02  0.33  0.01  0.13    0.00  0.01  0.00  0.00  0.00  0.15  0.00  0.50 
25-44  0.11    -0.03  0.45  0.03  0.24    0.01  0.09  0.01   -0.07  0.01  0.14  0.03  0.79 
45-64  0.76   0.32  0.23  0.02  0.36    0.06  0.63  0.26   -0.25  0.12  0.06  0.10  1.69 
65+   1.27   1.08  0.11  0.02  0.76    0.14  0.98  0.46   -0.18  0.09  0.03  0.05  3.25 
                          
total   2.15   1.39  1.12  0.07  1.50    0.21  1.72  0.73   -0.51  0.23  0.37  0.18  6.23 
 
Note: CVD-cardiovascular diseases. 
Source: World Health Organization (2006b). 
 
 
Table 8 shows the combined contributions of smoking-related cancers, cirrhosis of 
the liver, and external causes to sex differentials in mortality among Israeli Jews and 
elsewhere. 
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Table 8:  Contributions of causes of death representing major types of  
  avoidable mortality to sex differential in life expectancy at birth  










     years   
1950s     
  West   4.81   1.80   3.01 
  Israeli  Jews   2.86   1.32   1.54 
1970s     
  West   6.72   2.48   4.25 
  Israeli  Jews   3.22   1.24   1.97 
1990s     
  West   6.23   2.26   3.97 
  Israeli  Jews   4.03   1.28   2.75 
 
Note: (1) Figures may not sum exactly due to rounding. (2) Avoidable mortality is defined here as mortality 
from lung cancer, aerodigestive cancer, cirrhosis of the liver, and external causes. 
Source: Central Bureau of Statistics, Israel (Statistical Abstract of Israel, various years); special datafiles 
prepared by the Central Bureau of Statistics, Israel; World Health Organization (2006b). 
 
 
Avoidable mortality appears to contribute less significantly in absolute terms to the 
sex differentials among Israeli Jews relative to Western countries. If Western 
populations’ experience of sex differentials in mortality from major smoking-related 
cancers, cirrhosis of the liver, and external causes was similar to that observed among 
Israeli Jews, their total sex differential in life expectancy at birth could be reduced by 
one year or so in the 1970s and 1990s, and by half a year in the 1950s. The gap between 
Israeli Jews and other populations in relation to sex differentials would be smaller if 
only causes of non-avoidable mortality were allowed to operate in both populations. 
However, it is also apparent that the gap would not close completely as contributions of 
non-avoidable mortality are also smaller among Israeli Jews.  
To what extent do the findings presented in this section help to support or 
challenge the hypotheses earlier formulated by Staetsky and Hinde (2008) – about the 
female survival disadvantage and male survival advantage being a result of the migrant 
origin of Israeli Jews and the reduced impact of behaviourally induced (and especially 
smoking-related) mortality, respectively? With the data on causes of death that have 
been presented so far it is quite easy to see that the latter hypothesis is a plausible one. 
The level of mortality from lung cancer can be used as a proxy for estimating the 
overall impact of smoking on mortality in the given population (Lopez, Collishaw, and 
Piha. 1994, Peto et al. 1992, 1994). It has been pointed out in previous research that 
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lung cancer mortality is low among Israeli Jewish males (Rakower 1957, Rennert et al. 
1988, 1990, Lopez 1995). If we take the level of lung cancer mortality as an indicator of 
the overall impact of smoking, it is reasonable to expect that not only lung cancer, but 
many types of mortality in a society experiencing only a mild smoking epidemic would 
be low. This is precisely what is observed among Israeli Jewish males. Mortality in the 
Israeli Jewish male population is low also in relation to other typical behaviorally 
induced causes. This phenomenon has been noted in the Jewish population of Israel 
(Shuval 1992) but so far it has not been consistently employed for the explanation of 
the small sex differentials in mortality in this society.  
As for the hypothesis linking the elevated mortality of Jewish females to their 
migrant origin, partial evidence supporting the hypothesis was presented by Staetsky 
and Hinde (2008) where a relatively low overall level of mortality was identified in a 
population of Israeli-born females in the 1990s. Unfortunately, it is impossible to 
perform a decomposition of cause-specific contributions to the differential in life 
expectancy at birth of various foreign-born groups and Western females. This is so 
simply due to the nature of migration processes to Israel. The first generation of 
migrants has aged significantly since its arrival to Israel, ‘losing’ its infants, children, 
and young adults. Thus, life table functions cannot be computed for Israeli Jewish 
foreign-born populations. Such a decomposition, however, is possible for the Israeli-
born Jews, a population in which a full set of ages were present in the end of the 20
th 




4. Causes of death of Israeli-born Jews in comparative perspective  
In the mid-1990s, the Israeli-born Jewish population in Israel amounted to 2.8 million 
people, representing 61% of the total Jewish population of Israel (Central Bureau of 
Statistics, Israel, Statistical Abstract of Israel, 1997). In the 1990s the Israeli-born 
represented a majority at young ages, but were only a small minority at ages 65 years 
and over (Staetsky and Hinde 2008). Up until the 1990s the numbers of deaths in this 
population were too small to allow confident analysis of its causes-of-death profile. 
The life expectancy at birth of Israeli-born Jewish males and females in the mid-
1990s was 78.1 years and 81.4 years, respectively. Both figures were higher than the 
corresponding figures for Western countries at that time (74. 3 years and 80.6 years) 
and for the total population of Israeli Jews (76.3 years and 80.3 years). The male life 
expectancy at birth of Israeli-born Jews is significantly higher than in corresponding 
male populations comprising the comparative framework in this paper. The life 
expectancy of female Israeli-born Jews is still lower than that of females in France and 
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Switzerland, but it is higher than in most populations of comparator countries and is 
close to that observed in Sweden and Italy. The differential between female and male 
life expectancy at birth among Israeli-born Jews was 3.3 years, still very low and, in 
fact, even lower than that of the total Israeli Jewish population (4 years). It is definitely 
much lower than that observed in Western countries (6.3 years).  
Figure 4 and Table 9 present cause- and age-specific contributions to the 
difference in the life expectancy between Israeli-born Jewish males and females and 
their counterparts in Western countries in the 1990s. 
 
 
Figure 4:  Cause-specific contributions to the difference in life expectancy at  
  birth between Israeli-born Jews living in Israel and the population of  





















Note: CVD-cardiovascular diseases. 
Source: Special data files prepared by the Central Bureau of Statistics, Israel; World Health Organization 
(2006b). 
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Table 9:  Cause- and age-specific contributions to the difference in life  
  expectancy at birth between Israeli-born Jews living in Israel  
  and the population of Western countries, by sex, 1990s 
 
































































































































































   Israeli-born Jewish males living in Israel vs. Western males      
                    
0-24   0.03   0.01  0.22  0.02   -0.10    0.01  0.02  0.00 -   0.00  0.09  0.00  0.18 
25-44  0.09   0.04  0.32  0.01  0.13    0.03  0.05  0.01 -   0.01  0.09  0.04  0.58 
45-64  0.39   0.45  0.16  0.00  0.09    0.05  0.28  0.20 -   0.11  0.03  0.12  1.09 
65+   1.02   0.60  0.03   -0.01  0.25    0.26  0.55  0.35 -   0.05  0.00  0.05  1.90 
                            
total   1.53   1.10  0.73  0.02  0.37    0.35  0.90  0.56 -   0.17  0.20  0.21  3.75 
                    
   Israeli-born Jewish females living in Israel vs. Western females       
                    
0-24   0.02   0.01  0.08  0.01  0.03    0.00  0.02  0.00  0.00  0.00  0.04  0.00  0.15 
25-44  0.04   0.00  0.09  0.00  0.03    0.02  0.02  0.01   -0.01  0.00  0.02  0.02  0.17 
45-64  0.18   0.12  0.06   -0.01  0.05    0.07  0.10  0.07   -0.03  0.02  0.00  0.05  0.40 
65+   0.42   0.07  0.01   -0.08   -0.25    0.31   -0.01  0.07   -0.08  0.03  0.02  0.01  0.18 
                          
total   0.66   0.20  0.25   -0.08   -0.15    0.40  0.12  0.14   -0.12  0.05  0.08  0.08  0.89 
 
Note: CVD-cardiovascular diseases. 
Source: Special data files prepared by the Central Bureau of Statistics, Israel; World Health Organization (2006b). 
 
Israeli-born Jewish males show a very strong survival advantage relative to males 
in Western populations across all causes of death and in the majority of age groups. As 
with the total population of Israeli Jews, it is most prominent for CVD (both 
cerebrovascular disease and heart disease) and cancer, and especially lung and 
aerodigestive cancer. However, the survival advantage of Israeli-born Jewish males 
over males elsewhere in the Western world is even more pronounced than that of the 
total population of Israeli Jewish males. Note that in the 1990s mortality from CVD and 
cancer at ages 65 years and over contributes 1 year and 0.6 years, respectively, to the 
difference in life expectancy at birth between Israeli-born Jewish males and males in 
Western countries; the corresponding contributions of CVD and cancer in this age 
group to the difference between the total population of Israeli Jewish males and males 
in Western countries are approximately 0.5 years and 0.4 years (Table 2). A strong 
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survival advantage of Israeli-born Jewish males is also observed for external causes and 
cirrhosis of the liver.  
Israeli-born Jewish females, on the other hand, display a different positioning in 
relation to females in Western countries, when compared to the total population of 
Israeli Jewish females. Although less strong than in males, their positioning relative to 
females of Western countries is also clearly advantageous across many causes of death, 
including CVD (cerebrovascular and heart disease), total cancer, lung and aerodigestive 
cancer, external causes, and cirrhosis of the liver. It is also observed for most age 
groups. Note, for example, that in the 1990s mortality from CVD in age group 45 years 
and over contributed 0.6 years to the difference in life expectancy at birth between 
Israeli-born Jewish females and females in Western countries, and only 0.2 years to the 
difference between the total population of Israeli Jewish females and females of 
Western countries. Also, note that the contribution of all cancers is positive for Israeli-
born females, while it is negative for the total female population of Israeli Jews. Israeli-
born females are at disadvantageous positioning in relation to ‘other’ natural causes 
(causes other than CVD, cancer, and infectious diseases) and breast cancer. A large 
proportion of the disadvantage for the earlier group of causes comes from the ‘oldest 
old’ (females aged 80 years and over), and it is observed for all ages for breast cancer. 
Table 10 shows cause- and age-specific contribution to sex differentials in life 
expectancy among Israeli-born Jews and Western countries.  Sex differentials in 
mortality among Israeli-born Jews are significantly smaller than in Western countries 
for all causes of death. The difference in the size of contributions to life expectancy at 
birth between the sexes is nearly twofold, for example, for CVD (especially heart 
disease, rather less for cerebrovascular disease), and external causes, and even greater 
than that for cancer overall, lung cancer, and cirrhosis of the liver. For most causes they 
are also smaller than in the total population of Israeli Jews (Table 6). 
Table 11 shows contributions of avoidable mortality and the residual 
(nonavoidable mortality) to the difference in life expectancy between Israeli-born Jews 
living in Israel and Western countries, and to sex differentials in mortality in both 
settings. 
Here too, avoidable mortality is a significant contributor to the survival advantage 
of Israeli-born Jewish males, at a minimum it is responsible for about 44% of the 
difference between them and Western males. This proportion is lower than the same 
figure for all Israeli males (Table 3) but still very significant. Interestingly, Israeli-born 
Jewish females also show a prominent advantage in avoidable mortality, which 
accounts for over 60% of the difference between them and their counterparts in Western 
countries. Avoidable causes contribute more to sex differentials in Western countries 
than among Israeli-born Jews: the difference in the size of contributions is more than 
twofold. 
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Table 10:  Cause- and age-specific contributions to the difference in life  
  expectancy at birth between females and males among Israeli-born  
  Jews living in Israel and in the population of Western countries, 1990s 
 
































































































































































                  
   Israeli-born Jews living in Israel       
                    
0-24   0.00   0.02  0.19  0.00  0.27    0.00  0.00  0.00  0.00  0.00  0.10  0.00  0.48 
25-44  0.06    -0.08  0.22  0.02  0.15    0.00  0.06  0.00   -0.09  0.00  0.07  0.01  0.37 
45-64  0.55    -0.05  0.13  0.01  0.34    0.08  0.46  0.11   -0.30  0.03  0.02  0.02  0.98 
65+   0.48   0.64  0.11   -0.04  0.35    0.07  0.42  0.18   -0.30  0.08  0.06  0.01  1.54 
                          
total   1.09   0.53  0.65   -0.01  1.11    0.14  0.93  0.30   -0.69  0.11  0.25  0.04  3.37 
                     
   Western countries       
                    
0-24   0.01   0.02  0.33  0.01  0.13    0.00  0.01  0.00  0.00  0.00  0.15  0.00  0.50 
25-44  0.11    -0.03  0.45  0.03  0.24    0.01  0.09  0.01   -0.07  0.01  0.14  0.03  0.79 
45-64  0.76   0.32  0.23  0.02  0.36    0.06  0.63  0.26   -0.25  0.12  0.06  0.10  1.69 
65+   1.27   1.08  0.11  0.02  0.76    0.14  0.98  0.46   -0.18  0.09  0.03  0.05  3.25 
                          
total   2.15   1.39  1.12  0.07  1.50    0.21  1.72  0.73   -0.51  0.23  0.37  0.18  6.23 
 
Note: CVD-cardiovascular diseases. 
Source: Special datafiles prepared by the Central Bureau of Statistics, Israel; World Health Organization (2006b). 
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Table 11:  Contributions of causes of death representing major types of  
  avoidable mortality to the difference in life expectancy at birth  
  between Israeli-born Jews living in Israel and the population of  
  Western countries, and to sex differentials in mortality in both  









     years   
  Israeli-born Jews vs. Western countries 
  Males   3.75   1.66   2.09 
  Females   0.89   0.53   0.36 
  Sex differentials in mortality  
  Israeli-born  Jews     3.37   1.10   2.27 
  Western  countries   6.23   2.26   3.97 
 
Note: (1) Figures may not sum exactly due to rounding. (2) Avoidable mortality is defined here as 
mortality from lung cancer, aerodigestive cancer, cirrhosis of the liver, and external causes. 




The finding of relatively low mortality across many causes of death in Israeli-born 
Jewish females is probably one of the most convincing pieces of evidence that can 
support the hypothesis making the link between the elevated mortality of the total 
population of Israeli Jewish females and the migrant origin of the majority of its adult 
population. It is also evident that whatever factors are responsible for low mortality 
from smoking-related cancer, cirrhosis of the liver, and external causes, and a wide 
range of other causes among the total population of Israeli Jewish males, these factors 
are likely to operate also, and more strongly, among Israeli-born Jewish males than 
among all Israeli Jewish males. 
 
 
5. Discussion  
It has been shown that the phenomenon of relatively low male mortality among Israeli 
males is demonstrated across many causes of death. It is especially strong and 
consistent in relation to cancer and causes representing the so-called behaviourally 
induced largely avoidable mortality: lung and aerodigestive cancer, cirrhosis of the 
liver, and external causes. The pattern is less consistent for CVD. High female mortality 
is also observed across many causes of death, however this pattern is less definite than 
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the pattern exhibited by Israeli Jewish males. It is also most consistent in relation to 
cancer. CVD plays a prominent role in it during the 1970s but not in other periods. 
Breast cancer plays an important role in elevating female mortality from cancer as a 
whole in the 1990s, but it is much less prominent at earlier times.  In relation to all 
major causes female disadvantage gradually disappears between the 1950s and 1990s, 
and is only significant in the 1990s for ages 65 years and over. At no period could the 
strong survival disadvantage of Israeli Jewish females be attributed to the effects of 
smoking or other types of behaviourally induced mortality. All causes of death make 
smaller contributions to the difference in life expectancy between the sexes among 
Israeli Jews than in comparator countries. The described patterns are observed across 
the majority of age groups but, from the point of view of the life expectancy at birth, it 
is especially important that they are observed for age groups 45-64 years and 65 years 
and over. 
The irregular behaviour of CVD over the period of time under investigation is 
worth further consideration: this group of causes is a strong force in the Israeli Jewish 
female disadvantage in the 1970s and, though less strongly, also renders Israeli Jewish 
males a survival disadvantage in the same period. These features are not observed at 
any other point in time. Between the mid-1950s and the early 1970s the Israeli Jewish 
population underwent compositional change following the mass arrival of immigrants 
from the countries of the Middle East, North Africa, and Eastern Europe. Peritz et al. 
(1973) showed that these groups of new immigrants, both males and females, were 
characterized by especially high cardiovascular and total mortality relative to the earlier 
waves of immigration. 
The low mortality of Israeli Jewish males from major smoking-related cancers is a 
very significant finding. This is because the level of mortality from lung cancer is a 
good indicator of the overall impact of smoking (Lopez, Collishaw, and Piha 1994, Peto 
et al. 1992). Some part of the low male mortality in the Israeli Jewish population from 
causes other than smoking-related cancers might be due to the low impact of smoking. 
However, smoking does not appear to be the only factor here. It has been also shown 
that other types of behaviourally induced mortality are low in the Israeli male 
population across all ages. The lung cancer epidemic among Israeli females took a 
different route from that among females in other countries. Some (small) part of the 
elevated mortality of Israeli Jewish females in the 1950s and 1970s can be attributed to 
the effects of smoking. However, this is certainly not true of the 1990s simply because 
the effects of smoking in this population are lower in the 1990s than the average of 
other female populations. In a way very different from the Anglophone countries, for 
example, lung cancer mortality of Israeli Jewish females did not rise sharply in the 
1980s and 1990s, and, ultimately, never reached the average level observed among 
females in these countries.  
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The Israeli Jewish population of adult ages is dominated by the foreign-born 
element: at ages 65 years and over, for example, the proportion of foreign-born has 
never fallen below 80%; for ages 45 years and over it has never fallen below 55% 
(Central Bureau of Statistics, Israel, Statistical Abstract of Israel, various years). When 
the mortality of the Israeli-born population in the 1990s is compared to the average of 
Western countries, both male and female mortality appear to be lower than that in 
Western countries across nearly all causes of death. Avoidable mortality contributes 
significantly to the lower mortality of both Israeli-born Jewish males and females. It is 
also part of the explanation of a very low sex differential in mortality characteristic of 
Israeli-born Jews. Two hypotheses proposed by Staetsky and Hinde (2008), making a 
link between health protective behaviour and the migrant status of Israeli Jews and their 
low male and high female mortality, respectively, gain further support in light of the 
findings reported in this paper.  
Israeli Jewish mortality is usually examined within the context of developed 
countries (Thom et al. 1985, Uemura and Pisa 1988, Ore et al. 1991, Thom and Epstein 
1994, Manor et al. 1999, 2000, 2004). There is a more or less explicit assumption that 
its levels should be largely comparable to those observed in the developed world.   
However, on the basis of what is known about the operation of different determinants of 
mortality levels and trends, this comparative framework appears somewhat restrictive. 
If we take into consideration the entire range of mortality determinants operating in the 
Israeli case, and try to imagine various possibilities for their interplay, forming an 
expectation about Israeli Jewish mortality becomes a non-straightforward task. The 
origin of the Israeli Jewish population, lack of positive selection at migration, and 
Israel’s initially relatively low level of development might inflate mortality; while the 
existence of relatively advanced medicine, a healthy diet, and the mild impact of 
smoking, alcohol misuse, and accidental deaths might suppress it. To what extent do 
these forces offset each other? This is a question that is difficult to answer and, to date, 
it has not been posed in the context of research on Israeli Jewish mortality. If one is to 
take an unbiased look at the mortality determinants in the Israeli case, possibilities of 
both high and low mortality appear to be reasonable and should be allowed.  
There is one more important aspect to consider. Behavioural factors such as 
smoking, alcohol misuse, and risk taking are far more influential in relation to male 
mortality than to female mortality. Although in the second half of the 20
th century 
females became more similar to males across many types of behaviour (Waldron 1991, 
Nathanson 1995, Pampel 2001, 2002, 2003, 2005, Waldron, McCloskey, and Earle 
2005), neither smoking nor drinking and risk taking became equally prevalent among 
males and females. When relatively low levels of such behaviours are registered in a 
given society (Israeli Jewish society in this case), the benefits of this are unlikely to be 
shared equally by females and males in a sense that the male mortality of this society 
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might be low in relation to a certain set of comparators, while female mortality would 
not be necessarily as low in relation to the same set. A low impact of smoking, 
drinking, and risk taking would be more noticeable in relation to male mortality simply 
because these factors play a more prominent role in (and constitute a greater proportion 
of) male mortality. Female mortality better reflects the actual material conditions 
characteristic of the environment. Jewish females immigrated from societies with 
higher mortality and low socioeconomic conditions. Some of them spent a significant 
part of their lives (infancy, childhood and adolescence, and some part of adult life) in 
their societies of origin before immigrating to Israel. Therefore, Jewish females are, to a 
significant degree, products of their societies. The emerging body of evidence on early 
influences on adult mortality suggests that socioeconomic conditions experienced 
during gestation, infancy, and childhood may have a lasting impact on subsequent 
mortality from a wide range of causes, including cardiovascular diseases, cancer and 
diabetes (Elo and Preston 1992, Preston, Hill, and Drevenstedt 1998, Doblhammer 
2004, Galobardes, Lynch, and Davey Smith et al. 2004, 2008, Gluckman and Hanson 
2004, 2006, Hayward and Gorman 2004, Kuh and Ben-Shlomo 2004, Kuh and Davey 
Smith 2004, Lawlor, Ben-Shlomo, and Leon 2004, Godfrey 2006). Note, that although 
the female mortality of Jewish populations living in North America was higher than 
female mortality of their host populations before the 1970s, it became lower after the 
1970s (Needleman 1988, Rosenwaike 1990, 1994, Shatenstein and Kark 1995, 
Goldstein 1996, Shkolnikov et al. 2004). This process paralleled the reduction in the 
proportion of foreign-born in these populations (Staetsky and Hinde 2008).  
From this point of view, the ‘paradox’ of high Israeli Jewish female mortality, as 
described by Manor et al. (2000), is not really a paradox but something to be expected. 
This is not to say that the same factors pertaining to migrant origin do not affect Israeli 
Jewish male mortality. It is simply that their impact might be offset to a certain 
(unknown) extent by the effects of low behaviourally induced mortality. Note, for 
example, that although Israeli Jewish males have lower mortality from typical avoidable 
causes, there is no such consistent pattern for CVD, a cause relatively less affected by 
health destructive behaviour. Therefore, under present conditions (in general, the two 
sexes are unevenly affected by avoidable mortality, and in particular, the element of 
avoidable mortality is low among Israeli Jews), small sex differentials in mortality are 
essentially an arithmetical necessity.  
What accounts for the low behaviourally induced mortality among Israeli Jewish 
males? In the literature on Jewish mortality, inside and outside Israel health protective 
behaviour among Jews (and Jewish males in particular) was attributed to religious 
observance, the cohesive social structure of Jewish society, a sense of vulnerability 
among Jews in view of the negative attitudes of the non-Jewish population in countries 
of Jewish settlement, and, in more recent times (outside Israel) to the high 
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socioeconomic and educational status of Jews (Fishberg 1911, Hersch 1948, Schmelz 
1971, Glassner and Berg 1980, Condran and Kramarow 1991, Shuval 1992, Shatenstein 
and Kark 1995, Goldstein 1996, Almog 2000, Shkolnikov et al. 2004). Israeli Jewish 
society is heterogeneous in socioeconomic and educational terms, so it is sensible to 
discard the ‘socioeconomic’ argument in the present explanatory framework. 
Assessment of the possible impact of religiosity is a more complex matter. Earlier 
research within Israeli Jewish society suggested a link between religious observance 
and better health / lower mortality with ‘amelioration of stress’ as a major explanatory 
mechanism (Kark et al. 1996:345-346). It is important to remember, however, that 
Israeli Jewish society is also heterogeneous in terms of the degree of religious 
observance of its members.  
The social structure of Israeli Jewish society, both in religious circles and in 
secular society, is characterised by a significant cohesiveness and centrality of family 
life. Both factors imply a significant amount of social control on individual behaviour 
and the presence of emotional resources to build upon at times of distress. Both Lopez 
(1983) and Nathanson (1984) indicated in very general terms, that modernity, in a broad 
sense, favoured females more than it did males. In the transition to modernity males 
adopted a range of behaviours that ultimately harmed them. Smoking is one example of 
such behaviour but not the only one. As Pampel (2005) showed, the gap in survival 
between females and males from causes unrelated to smoking has been continuously 
widening. It has also been suggested in the literature that an increasingly individualistic, 
achievement-orientated culture might adversely affect male health, especially their 
health from cardiovascular diseases (Oman and Thoresen 1999). Up until the end of the 
20
th century, the divorce rate and the proportion of never married in Israeli Jewish 
population remained low, and its fertility remained relatively high
6. It is possible that a 
socially cohesive and family orientated culture would prove more beneficial for male 
health and survival than it would for females, making available to them emotional 
resources that would be unavailable otherwise and putting stronger social controls on 
their behaviour. This is simply so because the cultural elements would be important in 
prevention of health destructive behaviours, more characteristic of males than of 
females. This argument has been presented as relevant for the explanation of low male 
mortality among Jews in Canada (Shatenstein and Kark 1995)
7. Shuval (1992:77-78) 
perceived religiosity, the strength of family ties and a sense of solidarity of Israeli 
                                                           
6 The proportion of never married among those aged 45-49 years in the end of the 1980s was 3%-4% in Israel, 
5%-9% in the United Kingdom, 7%-9% in France, and 6%-10% in Germany (United Nations 1992). The total 
fertility rate of Israeli Jews was around 3.0 in the 1970s and 2.6 in the 1990s (Central Bureau of Statistics, 
Israel, Statistical Abstract of Israel, various years). 
7 And also by the Israeli demographer and sociologist Prof. Jon Anson, Ben-Gurion University of the Negev, 
in a private communication with the first author. 
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Jewish society stemming from political and military conflict with its neighbours as 
responsible for what she labels as a relative ‘immunity to social problems’ of Israeli 
Jewish society. More research is needed on the relative importance of the factors listed, 
as well as on the question of what makes Israeli Jewish males benefit more than males 
of other more traditional societies with some similar features of social structure, say 
Spanish, Italian or Greek males. Perhaps more attention should be given to arguments 
linking health protective behaviour and the great stress on self control among Jews to 
their sense of vulnerability, acquired as a result of the long history of political and 
religious conflict with their non-Jewish environment (Glassner and Berg 1980). 
The existence of genetic peculiarities in Jews was understood by certain scholars 
as relevant for explanation of patterns of Jewish mortality. Perhaps the strongest 
arguments were in relation to the high prevalence of genes predisposing to certain types 
of cancer among Jews (Feldman 2001, Shkolnikov et al. 2004, Lynch, Rubinstein, and 
Locker 2004). Genetic arguments exist also in relation to alcohol intolerance in Jews 
(Hasin et al. 2002). It is impossible, with the help of demographic tools only, to support 
or dismiss the possible role of genetic factors. If we take permanency of appearance of 
certain phenomena as an indication of genetic involvement in their creation, then the 
obvious candidate would be breast cancer in Israeli Jewish females. It is elevated at all 
points in time analysed in this study (1950s, 1970s, 1990s), and in the 1990s it is 
elevated for both foreign-born and Israeli-born Jewish females. There are indications, 
however, that mortality from breast cancer in Israeli Jews was lower than in developed 
countries through the 1980s. Also, the importance of breast cancer is very low in the 
1950s and appears to rise towards the 1990s. It is simply too dynamic to be an exclusive 
expression of elevated genetic susceptibility. Also, other types of cancer in Israeli 
Jewish females are dynamic and they diminish in importance for the explanation of the 
survival gap between them and the female populations of developed countries. Genetic 
influences might be important in explaining the low level of alcoholism among Israeli 
Jews, but powerful cultural explanations exist for this phenomenon (Glassner and Berg 
1980). The conclusion that is suggested by the finding of this paper, in our view, is that 
genetic factors are unlikely to be dominant forces of the observed patterns of female 
and male mortality at the population level.  
Importantly, we do not possess any direct evidence of institutional or any other 
discrimination against females in relation to medical care within the Israeli context. 
Within the context of developed countries, differential treatment of cardiovascular 
diseases in males and females is a well-documented phenomenon (Bennett and Redberg 
2004, Redberg 2004, Anand et al. 2005). It is less clear whether the differences in 
treatment reflect actual differences in the characteristics of cardiovascular disease in 
males and females, or whether they are due to a biased approach on the side of medical 
practitioners. There are no decisive conclusions in relation to the impact of the 
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differences in care on mortality outcomes of females and males (Redberg 2004, Anand 
et al. 2005).  
Preference for sons was documented by Okun (1996) in research on the fertility of 
Israeli Jewish females born in the countries of the Middle East. This can be treated as 
evidence of the presence of sex-biased attitudes characteristic of the Arab culture 
among the Middle Eastern Jews early in Israeli history. These attitudes dissolved 
following the exposure to the Europeanized context, however, and were not noticeable 
by the 1960s (Okun 1996). It is unlikely that these attitudes also resulted in differential 
access to medical treatment in these communities. Low male to female ratios of death 
rates in infancy and childhood are interpreted in the literature as evidence of the 
existence of a sex bias in nutrition and medical treatment in historical and developing 
societies (Tabutin and Willems 1995, Gjonca, Wilson, and Falkingham 1997, Yount 
2001). Male to female ratios of death rates at ages 0, 1-4, 5-9 and 10-14 years among 
Israeli Jews are decisively above unity (Staetsky and Hinde 2008), and, in most cases, 
are similar to those observed in developed countries. However, even this were true of 
the Jewish females of Middle Eastern origin, the level of Israeli Jewish female mortality 
is not determined by this group, as they are a minority among the adult and elderly 
population (their proportion of the population at adult ages has never exceeded 25%). It 
is European-born Jewish females whose mortality is mainly responsible for the 
observed pattern. 
To summarize, the results presented in this paper are suggestive of the centrality of 
the low impact of smoking and, in general, the health protective behaviour of Israeli 
Jewish males in sustaining the patterns of low mortality sex differentials in this 
population. The immigrant origin of Israeli Jewish females also appears to be important. 
It is for future research to establish the relative importance of various types of risk 
taking behaviour in the creation of the low male mortality phenomenon, and to develop 
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